•
Dec 31, 2016

Emergent BioSolutions Q4 2016 Earnings Report

Total Revenue
$152M
Previous year: $168M
-9.8%
EPS
$0.74
Previous year: $0.78
-5.1%
Gross Profit
$113M
Previous year: $128M
-11.6%
Cash and Equivalents
$272M
Previous year: $313M
-13.2%
Free Cash Flow
-$32.6M
Previous year: -$10.1M
+224.7%
Total Assets
$970M
Previous year: $1.04B
-6.5%

Emergent BioSolutions

Emergent BioSolutions